Title of article
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study
Author/Authors
Ludwig Kappos، نويسنده , , Mark S. Freedman، نويسنده , , Chris H. Polman، نويسنده , , Gilles Edan، نويسنده , , Hans-Peter Hartung، نويسنده , , David H Miller، نويسنده , , Xavier Montalban، نويسنده , , Frederik Barkhof، نويسنده , , Ernst-Wilhelm Radü، نويسنده , , Lars Bauer، نويسنده , , Susanne Dahms، نويسنده , , Vivian Lanius، نويسنده , , Christoph Pohl، نويسنده , , Rupert Sandbrink، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
9
From page
389
To page
397
Abstract
Background
Several controlled studies provide evidence that treatment with interferon beta in patients with a first event suggestive of multiple sclerosis (MS) delays conversion to clinically definite MS (CDMS). Our aim was to determine whether early init
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
591717
Link To Document